Answer
Mysimba should not be used in children and adolescents under 18 because its safety and efficacy have not been established in this age group.
Sources for this answer
- Mysimba 8 mg/90 mg prolonged-release tabletsOrexigen Therapeutics Ireland Limited · emc · SmPC §4.2 Posology and method of administration · Version 13Document updated
Sources checked